Insights for your outreach

Department Breakdown

Top Pharmaceutical Companies

Name: Top Pharmaceutical Companies
Creator: Surfe
Published: 2025-09-25 12:59:31
License: https://creativecommons.org/licenses/by-nc/4.0/

Last updated:25 Sep 2025

Created by Surfe | Views: 32

Market context behind this list

Sort by

Companies

Key Contacts

Annual Revenue

Funding

Company Growth

Team Growth

Hiring Status

Clear all

Annual Revenue

0-1M

1-10M

10-50M

50-100M

100-500M

500-1,000M

>1,000M

Clear all

Company Growth

1-20%

20-50%

50-100%

100%+

Clear all

Team Growth

1-20%

20-50%

50-100%

100%+

Clear all

Location

Dusseldorf, Germany

North Chicago, Illinois, United States

Berlin, Germany

Bern, Switzerland

San Rafael, California, United States

Lake Oswego, Oregon, United States

Buenos Aires, Argentina

Santa Cruz, United States

Varennes, Canada

Bethlehem, Pennsylvania, United States

Minneapolis, Minnesota, United States

Switzerland 🇨🇭, Switzerland

Kenilworth, United States

Louisville, Kentucky, United States

Rockville, Maryland, United States

Pudong, China

Abingdon, United Kingdom

Guadalajara, Mexico

Bad Homburg vor der Höhe, Germany

South Brunswick, New Jersey, United States

Paonta Sahib, India

Levallois-Perret, France

Jacksonville, United States

Memphis, Tennessee, United States

Saluggia, Italy

Craigavon, United Kingdom

Dublin, Ohio, United States

Zürich, Switzerland

Mayfield Heights, Ohio, United States

Barcelona, Spain

Quezon City, Philippines

Bad Homburg, Germany

Boulogne-Billancourt, France

Darmstadt, Germany

Fort Worth, Texas, United States

Waltham, Massachusetts, United States

Akishima, Japan

Shreveport, United States

St. John's, Canada

Florence, Italy

Mexico City, Mexico

Bad Vilbel, Germany

Cambridge, United Kingdom

Bridgewater, New Jersey, United States

Madrid, Spain

Easton, Massachusetts, United States

Waiblingen, Germany

Laval, Canada

Los Angeles, California, United States

Vernon Hills, United States

Hudson, Wisconsin, United States

Indianapolis, Indiana, United States

Singapore, Singapore

Dhaka, Bangladesh

Henderson, United States

Special capital Region of Jakarta, Indonesia

Wilmington, Delaware, United States

Hamburg, Germany

New Delhi, India

Newbury, Massachusetts, United States

Osted, Denmark

London, United Kingdom

Boston, Massachusetts, United States

Melbourne, Australia

Chiyoda, Japan

Durham, North Carolina, United States

Lisboa, Portugal

Warsaw, Poland

Mumbai, India

Anepura, India

Runcorn, United Kingdom

Highland Park, Michigan, United States

Hyderabad, India

Ahmedabad, India

Basel, Switzerland

Northampton, Massachusetts, United States

Marcy-l'Étoile, France

Dublin, Ireland

Burlington, Massachusetts, United States

Hoofddorp, Netherlands

Tejgaon Industrial Area, Bangladesh

Eastbourne, United Kingdom

Milton, Australia

Docklands, Australia

Midland, United States

Panchkula, India

New York, New York, United States

Secaucus, United States

Richmond, United States

Coventry, United Kingdom

Saint-Laurent-de-l'Île-d'Orléans, Canada

Orlando, Florida, United States

Clear all

	Companies		Key Contacts		Annual Revenue	Funding	Company Growth	Management Team Growth	Hiring Status	Tech Stack	HQ Location
1	Superdrug E-Commerce	2,214	Retail Sales Assistant, Sales Assistant, Assistant	>100	$500-1,000M		📉 Negative Growth: -1.47% 2,247 ↘ 2,214 Employees	📊 Modest Growth: 16.67% 6 ↗ 7 Employees	Actively Hiring	25	London, United Kingdom
2	Ebos Group Health Care	325	Business Insights Specialist, Principal Quality Specialist Healthcare Logistics, Head of Data Platforms & Engineering	>100	$>1,000M		📊 Modest Growth: 1.56% 320 ↗ 325 Employees	📊 Modest Growth: 7.69% 13 ↗ 14 Employees	Actively Hiring	27	Docklands, Australia
3	BioMarin Pharmaceutical Biotechnology	2,850	Vice President, Global Study Operations, Manufacturing Associate, Senior Quality Control Analyst	>100	$>1,000M	$585M raised Post-IPO Debt, 05-11-2020	📊 Modest Growth: 0.49% 2,836 ↗ 2,850 Employees	📊 Modest Growth: 5.88% 51 ↗ 54 Employees	Actively Hiring	24	San Rafael, California, United States
4	Lux med Health Care	1,618	Rejestrator medyczny, Kierownik centrum medycznego, Menedżer ds. Zakupów	>100	$500-1,000M		📊 Modest Growth: 0.75% 1,606 ↗ 1,618 Employees	📊 Modest Growth: 4.35% 23 ↗ 24 Employees	Actively Hiring	0	Warsaw, Poland
5	Incyte Pharmaceutical	2,197	Senior Principle Biostatistical Programmer, Oncology Business Director, Director, Clinical Project Management	>100	$>1,000M		📊 Modest Growth: 3.34% 2,126 ↗ 2,197 Employees	📊 Modest Growth: 4.17% 72 ↗ 75 Employees	Actively Hiring	33	Wilmington, Delaware, United States
6	Omnicell Health Care	2,219	Facilities Manager, Director of Store Support, Logistics	>100	$500-1,000M	$150M raised Post-IPO Debt, 11-20-2024	📉 Negative Growth: -0.14% 2,222 ↘ 2,219 Employees	📊 Modest Growth: 3.45% 29 ↗ 30 Employees	Actively Hiring	13	Fort Worth, Texas, United States
7	Gerresheimer Manufacturing	1,724	Meio Oficial Preparador de Máquinas de Serigrafia, Operador de maquinário, Global Director Key Account Management	>100	$>1,000M	$298M raised Post-IPO Equity, 04-18-2023	⏸️ No Growth: 0% 1,724 Employees	📊 Modest Growth: 3.03% 33 ↗ 34 Employees	Actively Hiring	12	Dusseldorf, Germany
8	Eli Lilly Pharmaceutical	34,223	Reimbursement Specialist, Sr. Biologist, Executive Director, Biology	>100	$>1,000M		📊 Modest Growth: 4% 32,906 ↗ 34,223 Employees	📊 Modest Growth: 2.47% 770 ↗ 789 Employees	Actively Hiring	0	Indianapolis, Indiana, United States
9	Zuellig Pharma Health Care	2,168	Digital marketing assistant manager, Inbound Sales Representative, CAMG	>100	$500-1,000M		📊 Modest Growth: 0.09% 2,166 ↗ 2,168 Employees	📊 Modest Growth: 2.33% 43 ↗ 44 Employees	Actively Hiring	15	Singapore, Singapore
10	Vertex Pharmaceuticals Health Care	5,551	Senior Director, International Privacy, San Diego Learning Lab High School Intern, Senior Manager. GDP Market Quality.	>100	$>1,000M	$1M raised Post-IPO Secondary, 07-10-2024	📊 Modest Growth: 1.82% 5,452 ↗ 5,551 Employees	📊 Modest Growth: 0.78% 129 ↗ 130 Employees	Actively Hiring	16	Boston, Massachusetts, United States
11	Dr. Reddy’s Laboratories Ltd Biotechnology	12,258	Специалист отдела регистрации лек. средств, Process Engineer / Scientist, Medical Administrative Assistant	>100	$>1,000M		📉 Negative Growth: -0.4% 12,307 ↘ 12,258 Employees	📊 Modest Growth: 0.6% 333 ↗ 335 Employees	Actively Hiring	15	Hyderabad, India
12	Torrent Pharmaceuticals Pharmaceutical	4,743	Medical advisor, Scientist, Area Sales Manager	>100	$500-1,000M	$366M raised Post-IPO Secondary, 10-30-2024	📉 Negative Growth: -0.57% 4,770 ↘ 4,743 Employees	📊 Modest Growth: 0.38% 796 ↗ 799 Employees	Actively Hiring	12	Ahmedabad, India
13	AstraZeneca Health Care	54,449	Pharmaceutical Sales Specialist, Senior Scientific Developer, Oncology and Hematology Business Unit Director	>100	$>1,000M	$1,514M raised Post-IPO Debt, 07-30-2024	📊 Modest Growth: 0.23% 54,322 ↗ 54,449 Employees	📊 Modest Growth: 0.33% 614 ↗ 616 Employees	Actively Hiring	25	Cambridge, United Kingdom
14	Roche Biotechnology	45,748	Customer Experience Specialist (Japanese Speaking), Senior Engineer Post-Market Quality, B. Sc. Pharm	>100	$>1,000M	$5,000M raised Post-IPO Equity, 08-04-2021	📊 Modest Growth: 0.9% 45,342 ↗ 45,748 Employees	📊 Modest Growth: 0.33% 303 ↗ 304 Employees	Actively Hiring	15	Switzerland 🇨🇭, Switzerland
15	Amneal Pharmaceuticals Health Care	3,362	Officer, Senior Director, Oncology Marketing, Assistant	>100	$500-1,000M	$2,350M raised Post-IPO Debt, 11-16-2023	📊 Modest Growth: 0.24% 3,354 ↗ 3,362 Employees	📊 Modest Growth: 0.21% 484 ↗ 485 Employees	Actively Hiring	37	Bridgewater, New Jersey, United States
16	Merck Biotechnology	25,095	Principal Scientist, Compliance Specialist, Quality System Specialist	>100	$>1,000M		📊 Modest Growth: 0.16% 25,054 ↗ 25,095 Employees	📊 Modest Growth: 0.16% 616 ↗ 617 Employees	Actively Hiring	17	Kenilworth, United States
17	Coloplast College Health Care		Shift Coordinator	+1	$500-1,000M		⏸️ No Growth: 0% Employees	⏸️ No Growth: 0% Employees	Not Hiring	14	Hamburg, Germany
18	Sigma-Aldrich Chemical	5,851	Client Development Analist, Senior Analyst, Project Manager	>100	$500-1,000M		📊 Modest Growth: 0.48% 5,823 ↗ 5,851 Employees	⏸️ No Growth: 0% 24 Employees	Actively Hiring	14	Burlington, Massachusetts, United States
19	AbbVie Health Care	36,765	Director, Global Advanced Analytics, Associate Scientist II, Director, National Accounts	>100	$>1,000M	$15,000M raised Post-IPO Debt, 02-27-2024	📊 Modest Growth: 0.74% 36,495 ↗ 36,765 Employees	⏸️ No Growth: 0% 387 Employees	Actively Hiring	18	North Chicago, Illinois, United States
20	Lazz Pharma Manufacturing	60	Order Selector, Madecal Divice, Assistant Manager	>100	$500-1,000M		📊 Modest Growth: 3.45% 58 ↗ 60 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	15	Dhaka, Bangladesh
21	Lonza Health Care	11,017	CQV engineer, Associate Director EHS, Principal Scientist	>100	$500-1,000M	$444M raised Post-IPO Debt, 11-06-2023	📊 Modest Growth: 1.03% 10,905 ↗ 11,017 Employees	⏸️ No Growth: 0% 46 Employees	Actively Hiring	24	Basel, Switzerland
22	PharMerica Health Care	1,564	Parmacist, Senior Vice President, Purchasing and Trade Relations, Pharmacist	>100	$500-1,000M		📉 Negative Growth: -0.38% 1,570 ↘ 1,564 Employees	⏸️ No Growth: 0% 20 Employees	Actively Hiring	26	Louisville, Kentucky, United States
23	Unilabs Health Care	9	Director de administración de datos, Facultativa Especialista en Microbiología Clínica, Tecnico de imagen para el diagnóstico y medicina nuclear	+10	$500-1,000M		⏸️ No Growth: 0% 9 Employees	⏸️ No Growth: 0% Employees	Not Hiring	33	Madrid, Spain
24	Cardinal Health Health Care	16,286	Recruiter, Director, Intercompany COE and Corporate Consolidations, Country Manager Iberia	>100	$>1,000M	$78M raised Post-IPO Debt, 08-16-2006	📊 Modest Growth: 0.27% 16,242 ↗ 16,286 Employees	⏸️ No Growth: 0% 170 Employees	Actively Hiring	14	Dublin, Ohio, United States
25	''United States Pharmacopeia'' Biotechnology	935	Director - Biologics, Global and Federal Practice Program Manager, Project Manager - IT	>100	$500-1,000M		📉 Negative Growth: -1.27% 947 ↘ 935 Employees	⏸️ No Growth: 0% 18 Employees	Actively Hiring	24	Rockville, Maryland, United States
26	Psychedelic Invest - Insights and Analyses on Psychedelics Pharmaceutical	4	Freelance Writer	+1	$500-1,000M		⏸️ No Growth: 0% 4 Employees	⏸️ No Growth: 0% Employees	Not Hiring	30	London, United Kingdom
27	Melaleuca: The Wellness Company Health Care		Assistant, Health and Wellness Business Owner, Founder/Director	+26	$500-1,000M		⏸️ No Growth: 0% Employees	⏸️ No Growth: 0% Employees	Not Hiring	21	Easton, Massachusetts, United States
28	Csl Health Care	8,768	Customer Service Representative, Certified Phlebotomy Technician, Medical Information Specialist (Hematology)	>100	$500-1,000M	$111M raised Post-IPO Equity, 02-06-2004	📊 Modest Growth: 0.45% 8,729 ↗ 8,768 Employees	⏸️ No Growth: 0% 112 Employees	Actively Hiring	11	Melbourne, Australia
29	Kirkman Health Care	12	Chief Executive Officer, Receptionist, Customer Service/Marketing	+24	$500-1,000M		📉 Negative Growth: -7.69% 13 ↘ 12 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	25	Lake Oswego, Oregon, United States
30	Delhi Pharmaceutical Sciences and Research University DPSRU Pharmaceutical	89	Research Scholar, Ph.D, Associate Professor and Head SOP DPSRU	>100	$500-1,000M		📉 Negative Growth: -1.11% 90 ↘ 89 Employees	⏸️ No Growth: 0% Employees	Not Hiring	6	New Delhi, India
31	Peptide Sciences Dietary Supplements	1	Packager, Online Sales Manager, Scientist	+3	$500-1,000M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% Employees	Not Hiring	3	Henderson, United States
32	Héma-Québec Health Care	864	Donneur de plasma, Spécialiste Contrôle Qualité, specialiste progiciel production	>100	$500-1,000M		📊 Modest Growth: 0.23% 862 ↗ 864 Employees	⏸️ No Growth: 0% 8 Employees	Actively Hiring	14	Saint-Laurent-de-l'Île-d'Orléans, Canada
33	Lynnfield Drug Health Care	114	Pharmacy Technician, Pharmacy Operations Sr Supervisor, Clinical Pharmacist	>100	$500-1,000M		📊 Modest Growth: 2.7% 111 ↗ 114 Employees	⏸️ No Growth: 0% 1 Employees	Actively Hiring	21	Newbury, Massachusetts, United States
34	Quest Diagnostics Health Care	13,048	Scientist Certifying-Positive, Courier, PS Supervisor	>100	$>1,000M	$1,850M raised Post-IPO Debt, 08-15-2024	📉 Negative Growth: -0.1% 13,061 ↘ 13,048 Employees	⏸️ No Growth: 0% 90 Employees	Actively Hiring	20	Secaucus, United States
35	Aptar Pharmaceutical	2,907	Gestionnaire Finition, Technicien Essais Mécaniques, Physiques et Fonctionnels, Junior Account Manager	>100	$>1,000M		📉 Negative Growth: -0.38% 2,918 ↘ 2,907 Employees	⏸️ No Growth: 0% 36 Employees	Actively Hiring	38	Midland, United States
36	Ppd, Inc. Biotechnology	16,349	Senior Director Project Management, Medical Information Specialist, Country Approval Associate	>100	$500-1,000M		📉 Negative Growth: -0.78% 16,477 ↘ 16,349 Employees	⏸️ No Growth: 0% 235 Employees	Not Hiring	37	Waltham, Massachusetts, United States
37	Bausch Health Health Care	1,898	Pharmacy Business Manager, Account Exceutive, HR& Administration Director	>100	$500-1,000M	$600M raised Post-IPO Debt, 07-07-2023	📉 Negative Growth: -0.05% 1,899 ↘ 1,898 Employees	⏸️ No Growth: 0% 37 Employees	Actively Hiring	17	Laval, Canada
38	Verband Forschender Arzneimittelhersteller e.V. VFA Health Care	35	Referentin Länderkoordination Gesundheitswirtschaft, Brand, Strategische Partnerschaften, Events, HR-Managerin	+41	$500-1,000M		📊 Modest Growth: 2.94% 34 ↗ 35 Employees	⏸️ No Growth: 0% 3 Employees	Not Hiring	12	Berlin, Germany
39	thuisvaccinatie.nl Health Care	21	Recruitment Basis Artsen, Financiële administratie, Co-Founder	+30	$500-1,000M		⏸️ No Growth: 0% 21 Employees	⏸️ No Growth: 0% 2 Employees	Actively Hiring	19	Hoofddorp, Netherlands
40	3m Company Canada Innovation Management	7	Production Operator, Senior Account Executive, Product Engineering Specialist/ Project Manager	+13	$500-1,000M		📊 Modest Growth: 16.67% 6 ↗ 7 Employees	⏸️ No Growth: 0% Employees	Not Hiring	24	St. John's, Canada
41	Caeme Health Care	17	Business Intelligence Analyst, Asesor médico, Gerente de Relaciones Institucionales	+24	$500-1,000M		⏸️ No Growth: 0% 17 Employees	⏸️ No Growth: 0% 2 Employees	Not Hiring	31	Buenos Aires, Argentina
42	Menarini Group Pharmaceutical	3,170	TECNICO, Sales Manager, Impiegato amministrativo	>100	$500-1,000M		📉 Negative Growth: -0.47% 3,185 ↘ 3,170 Employees	⏸️ No Growth: 0% 47 Employees	Actively Hiring	26	Florence, Italy
43	Daiichi Sankyo Biotechnology	850	Global Head, Project Management and Operational Excellence, 主任, Senior Director	>100	$500-1,000M		📊 Modest Growth: 1.8% 835 ↗ 850 Employees	⏸️ No Growth: 0% 32 Employees	Actively Hiring	15	Chiyoda, Japan
44	AbbVie Biotechnology	140	Treasury Analyst, Assistant, Administrative Assistant III	>100	$500-1,000M		📉 Negative Growth: -1.41% 142 ↘ 140 Employees	⏸️ No Growth: 0% 2 Employees	Not Hiring	0	Zürich, Switzerland
45	Pentax Medical Health Care	242	Senior Manufacturing Executive, Administration / Human Resources, Product Manager	>100	$500-1,000M	$125k raised Grant, 12-09-2019	📉 Negative Growth: -1.22% 245 ↘ 242 Employees	⏸️ No Growth: 0% 9 Employees	Actively Hiring	15	Akishima, Japan
46	Pharmalex GmbH Consulting	221	Rechtsanwältin und Partnerin von Pharmalex GmbH, Senior Finance Director DACH & Eastern Europe, Rechtsanwältin	+3	$0-1M		📊 Modest Growth: 2.31% 216 ↗ 221 Employees	⏸️ No Growth: 0% 5 Employees	Not Hiring	17	Bern, Switzerland
47	Microdose Psychedelic Insights Health Care		Chief Executive Officer, Praktikant	+2	$500-1,000M		⏸️ No Growth: 0% Employees	⏸️ No Growth: 0% Employees	Not Hiring	30	Santa Cruz, United States
48	Illuminate Labs® Health Care	12	Dermatology reviewer, Medical Reviewer, President	+3	$500-1,000M		⏸️ No Growth: 0% 12 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	19	Northampton, Massachusetts, United States
49	Sanfer Health Care	908	Gerente Distrito, Representante médico, Gerente Corporativo de Farmaco-Tecnovigilancia Mexico & LATAM	>100	$500-1,000M	$500M raised Private Equity Round, 08-19-2019	📉 Negative Growth: -0.77% 915 ↘ 908 Employees	⏸️ No Growth: 0% 12 Employees	Actively Hiring	8	Mexico City, Mexico
50	Jean Coutu Pharmaceutical	2,160	Adjointe exécutive - Pharmacie et soins de santé, Agile Coach, Graphiste	>100	$500-1,000M		📉 Negative Growth: -1.23% 2,187 ↘ 2,160 Employees	⏸️ No Growth: 0% 54 Employees	Actively Hiring	18	Varennes, Canada
51	Zeon Lifesciences Health Care	203	Fresher, Warehouse Officer, Quality Assurance Trainee	>100	$500-1,000M		📉 Negative Growth: -0.49% 204 ↘ 203 Employees	⏸️ No Growth: 0% 15 Employees	Actively Hiring	21	Paonta Sahib, India
52	Sisco Research Laboratories Biotechnology	136	Office Executive, Team Lead, Maintenance Engineer	>100	$500-1,000M		📊 Modest Growth: 0.74% 135 ↗ 136 Employees	⏸️ No Growth: 0% 5 Employees	Actively Hiring	10	Mumbai, India
53	Pharmaffiliates Biotechnology	153	Executive, Sr Data analyst, Business Development Manager	>100	$500-1,000M		📉 Negative Growth: -3.77% 159 ↘ 153 Employees	⏸️ No Growth: 0% 36 Employees	Not Hiring	23	Panchkula, India
54	Orion Group Pharmaceutical	226	Human Resources Executive, Distributon In-Charge, Executive	>100	$500-1,000M		📉 Negative Growth: -2.16% 231 ↘ 226 Employees	⏸️ No Growth: 0% 35 Employees	Not Hiring	10	Tejgaon Industrial Area, Bangladesh
55	WholeScripts Health Care	3	Business Analyst, Customer Service Representative, Senior Functional Medicine Consultant	+4	$500-1,000M		⏸️ No Growth: 0% 3 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	16	Orlando, Florida, United States
56	B. Braun Medical Health Care	2,750	Quality Systems Manager III, operation, Senior Clinical Procedure Specialist	>100	$500-1,000M	$25k raised Debt Financing, 10-27-2020	📊 Modest Growth: 0.04% 2,749 ↗ 2,750 Employees	⏸️ No Growth: 0% 52 Employees	Actively Hiring	8	Bethlehem, Pennsylvania, United States
57	Seed Health Biotechnology	166	Teacher, lebra job, USA army	+5	$500-1,000M	$40M raised Series A, 04-21-2021	📉 Negative Growth: -5.68% 176 ↘ 166 Employees	⏸️ No Growth: 0% 6 Employees	Actively Hiring	46	Los Angeles, California, United States
58	BC30 Probiotic Biotechnology	5	Chief Scientific Officer & Director, Vice President, Director of Research and Development	+9	$500-1,000M		⏸️ No Growth: 0% 5 Employees	⏸️ No Growth: 0% 2 Employees	Not Hiring	18	Mayfield Heights, Ohio, United States
59	The ACME Laboratories Manufacturing	884	Executive, Global Regulatory Affairs, Regulatory Affairs Executive, Senior Project Manager	>100	$500-1,000M		📊 Modest Growth: 0.11% 883 ↗ 884 Employees	⏸️ No Growth: 0% 144 Employees	Not Hiring	28	Dhaka, Bangladesh
60	The Rockefeller University Biotechnology	1,016	Other, Accounts Payable Administrator, research associate	>100	$500-1,000M	$2M raised Grant, 01-01-2020	📉 Negative Growth: -0.49% 1,021 ↘ 1,016 Employees	⏸️ No Growth: 0% 5 Employees	Not Hiring	32	New York, New York, United States
61	Vikas Lifecare Consulting	2	Chief Financial Officer, Account Manager, Chief Executive Officer	+3	$500-1,000M		⏸️ No Growth: 0% 2 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	24	New Delhi, India
62	IndusViva healthsciences Health Care	38	MLM distributor, Network Marketer, Retired	>100	$500-1,000M		📉 Negative Growth: -2.56% 39 ↘ 38 Employees	⏸️ No Growth: 0% 10 Employees	Not Hiring	21	Anepura, India
63	Biogroup Biotechnology	1,061	Technicienne en laboratoire, Infirmier, Gestionnaire de stock	>100	$500-1,000M	$3,030M raised Debt Financing, 02-12-2021	📉 Negative Growth: -1.12% 1,073 ↘ 1,061 Employees	⏸️ No Growth: 0% 16 Employees	Actively Hiring	27	Levallois-Perret, France
64	PRBB Barcelona Biomedical Research Park Biotechnology	67	Machine Learning Researcher, Office Assistant, Technical Specialist	+75	$500-1,000M		📊 Modest Growth: 1.52% 66 ↗ 67 Employees	⏸️ No Growth: 0% Employees	Not Hiring	14	Barcelona, Spain
65	Convatec Holdings UK Ltd Health Care	17	Superintendente de DO e Integración, Responsable de secteur cicatrisation, Técnico de automatización	+82	$500-1,000M		⏸️ No Growth: 0% 17 Employees	⏸️ No Growth: 0% Employees	Not Hiring	12	Osted, Denmark
66	Bio-Techne Biotechnology	1,408	Senior Controls Engineer, International Customer Care Representative at Bio-Techne, Product Marketing Specialist	>100	$500-1,000M		📉 Negative Growth: -0.28% 1,412 ↘ 1,408 Employees	⏸️ No Growth: 0% 16 Employees	Actively Hiring	17	Minneapolis, Minnesota, United States
67	AIM at Melanoma Health Care	8	Moffitt Melanoma Research Ambassador, Director of Medical Education, National Director	+8	$500-1,000M		⏸️ No Growth: 0% 8 Employees	⏸️ No Growth: 0% 2 Employees	Not Hiring	39	Richmond, United States
68	Qualfon Outsourcing	1,831	Bpo sales, Customer service representative, Customer Service Representative	>100	$500-1,000M		📉 Negative Growth: -1.66% 1,862 ↘ 1,831 Employees	⏸️ No Growth: 0% 26 Employees	Actively Hiring	27	Highland Park, Michigan, United States
69	Vita Living Dietary Supplements		Administration Assistant, Care giver, Owner	+8	$500-1,000M		⏸️ No Growth: 0% Employees	⏸️ No Growth: 0% Employees	Not Hiring	43	Shreveport, United States
70	Mercury Drug Pharmaceutical	262	Pharmacy Assistant, Pharmacy Assistant, Pharmacy Cashier	>100	$500-1,000M		📉 Negative Growth: -1.87% 267 ↘ 262 Employees	⏸️ No Growth: 0% 4 Employees	Not Hiring	9	Quezon City, Philippines
71	WholisticResearch Health Care	1	Chief Executive Officer	+1	$500-1,000M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	23	Eastbourne, United Kingdom
72	Als Limited Pharmaceutical	4,271	inginer chimist, Client Manager, Team Lead login	>100	$>1,000M		📉 Negative Growth: -1.07% 4,317 ↘ 4,271 Employees	⏸️ No Growth: 0% 67 Employees	Actively Hiring	23	Milton, Australia
73	PHOENIX Medical Supplies Pharmaceutical	222	Senior Maintenance Technician, Business Intelligence Developer, Pharmacy Technician	>100	$500-1,000M		📉 Negative Growth: -0.89% 224 ↘ 222 Employees	⏸️ No Growth: 0% 3 Employees	Actively Hiring	8	Runcorn, United Kingdom
74	R&D Systems Biotechnology	153	System Administrator, Project Manager, Test Development Engineer	>100	$500-1,000M		⏸️ No Growth: 0% 153 Employees	⏸️ No Growth: 0% Employees	Not Hiring	22	Abingdon, United Kingdom
75	BioMerieux Biotechnology	8,309	Commercial Performance Manager, Technicien, Senior Process Technician	>100	$>1,000M		📊 Modest Growth: 0.65% 8,255 ↗ 8,309 Employees	⏸️ No Growth: 0% 83 Employees	Actively Hiring	15	Marcy-l'Étoile, France
76	PiSA Pharmaceutical Health Care	3,697	Analista de validación, Director Compensation & Benefits, Coordinador Funcional SAP MM	>100	$500-1,000M		📊 Modest Growth: 0.52% 3,678 ↗ 3,697 Employees	⏸️ No Growth: 0% 29 Employees	Actively Hiring	20	Guadalajara, Mexico
77	Fresenius SE & Co. KGaA Health Care	1	Senior Architect - SAP BTP Integration Lead, Patient Care Technician, Geschäftsbereichsleiter Finanzen & Controlling \| Prokurist	>100	$>1,000M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% Employees	Not Hiring	6	Bad Homburg, Germany
78	SOHO Global Health Health Care	396	Operator produksi, Senior SFE Manager, karyawati	>100	$500-1,000M		⏸️ No Growth: 0% 396 Employees	⏸️ No Growth: 0% 8 Employees	Not Hiring	7	Special capital Region of Jakarta, Indonesia
79	Hamdard Laboratories Waqf Bangladesh Health Care	43	Sr. Asst. Manager, In-Charge (Microbiology), Factory Worker, Director Marketing & Sales	+74	$500-1,000M		⏸️ No Growth: 0% 43 Employees	⏸️ No Growth: 0% 4 Employees	Not Hiring	20	Dhaka, Bangladesh
80	Uniphar Group Health Care	168	Commercial Financial Accountant, Pharmacy Assistant, HR Business Partner	>100	$500-1,000M		📉 Negative Growth: -1.18% 170 ↘ 168 Employees	⏸️ No Growth: 0% 4 Employees	Actively Hiring	19	Dublin, Ireland
81	PharmaLex Pharmaceutical	1,190	Senior Manager Regulatory Affairs, Pharmacovigilance Manager, Director, Business Development	>100	$500-1,000M		📉 Negative Growth: -1.41% 1,207 ↘ 1,190 Employees	⏸️ No Growth: 0% 15 Employees	Actively Hiring	24	Bad Homburg vor der Höhe, Germany
82	World Courier Delivery Service	1,510	driver, Global Logistics Coordinator II, Dispatcher	>100	$500-1,000M		📉 Negative Growth: -0.66% 1,520 ↘ 1,510 Employees	⏸️ No Growth: 0% 46 Employees	Actively Hiring	6	London, United Kingdom
83	Delpharm Pharmaceutical	1,279	Conducteur de ligne, Ouvrier production, Ingénieure efficacité énergétique	>100	$500-1,000M		📉 Negative Growth: -0.47% 1,285 ↘ 1,279 Employees	⏸️ No Growth: 0% 9 Employees	Actively Hiring	8	Boulogne-Billancourt, France
84	Diasorin Biotechnology	1,540	International Marketing Consultant at IDS (UK), PM at Pantec srl (I), Senior Scientist, Manager, Scientist III	>100	$500-1,000M		📊 Modest Growth: 0.92% 1,526 ↗ 1,540 Employees	⏸️ No Growth: 0% 39 Employees	Actively Hiring	21	Saluggia, Italy
85	Renue By Science Dietary Supplements	7	Research Director, Research Assistant & Content Manager, Director of Social & Organic Marketing	+9	$500-1,000M		⏸️ No Growth: 0% 7 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	36	Jacksonville, United States
86	LloydsPharmacy Health Care	761	Pharmacy Technician, Senior Pharmacist, Pharmacy Assistant	>100	$500-1,000M		📉 Negative Growth: -2.06% 777 ↘ 761 Employees	⏸️ No Growth: 0% 9 Employees	Not Hiring	21	Coventry, United Kingdom
87	Stada Health Care	1,778	Office Coordinator, Brand Manager, Country Manager	>100	$500-1,000M		📊 Modest Growth: 0.85% 1,763 ↗ 1,778 Employees	⏸️ No Growth: 0% 41 Employees	Actively Hiring	12	Bad Vilbel, Germany
88	Antylia Scientific Biotechnology	348	Sourcing and Procurement Specialist, Inventory Controller, Order Entry Specialist	>100	$500-1,000M		📉 Negative Growth: -1.42% 353 ↘ 348 Employees	⏸️ No Growth: 0% 4 Employees	Actively Hiring	28	Vernon Hills, United States
89	Alkermes Health Care	1,630	Territory Business Manager, Director, Commercial Effectiveness, Associate Director, Local Market Development & Brand Strategy	>100	$500-1,000M		📊 Modest Growth: 1.24% 1,610 ↗ 1,630 Employees	⏸️ No Growth: 0% 40 Employees	Actively Hiring	25	Dublin, Ireland
90	Almac Group Pharmaceutical	3,096	Senior Preformulation Scientist, Senior Project Specialist, Admin Assistant/Receptionist	>100	$500-1,000M	$1M raised Grant, 12-04-2019	📊 Modest Growth: 0.81% 3,071 ↗ 3,096 Employees	⏸️ No Growth: 0% 15 Employees	Actively Hiring	31	Craigavon, United Kingdom
91	Macleod Pharmaceuticals Manufacturing	4,898	Medical Sales Representative, Secretary, Reserch Associate	>100	$500-1,000M		📉 Negative Growth: -0.69% 4,932 ↘ 4,898 Employees	⏸️ No Growth: 0% 312 Employees	Not Hiring	25	Mumbai, India
92	Syntegon Manufacturing	1,995	Sales Manager, Field Technician, Constructeur Mechanisch	>100	$500-1,000M		📊 Modest Growth: 0.55% 1,984 ↗ 1,995 Employees	⏸️ No Growth: 0% 26 Employees	Actively Hiring	19	Waiblingen, Germany
93	Parexel Clinical Trials	14,364	Sr. Clinical Operations Lead, Director, Site Solutions, Head of Americas, Drug Safety Associate	>100	$500-1,000M		📉 Negative Growth: -0.29% 14,406 ↘ 14,364 Employees	⏸️ No Growth: 0% 118 Employees	Actively Hiring	19	Durham, North Carolina, United States
94	R-Biopharm AG Biotechnology	238	International Sales, Entwicklerin, Produktionsaufsicht	>100	$500-1,000M		⏸️ No Growth: 0% 238 Employees	⏸️ No Growth: 0% 4 Employees	Actively Hiring	40	Darmstadt, Germany
95	Phillips Medisize Manufacturing	1,402	Project Manager, Electro Mechanical Technician, Production Technician	>100	$500-1,000M		📊 Modest Growth: 0.94% 1,389 ↗ 1,402 Employees	⏸️ No Growth: 0% 13 Employees	Actively Hiring	26	Hudson, Wisconsin, United States
96	Accredo Health Care	1,927	Staff Pharmacist, patient care advocate, Lead nurse clinician	>100	$500-1,000M		📊 Modest Growth: 0.26% 1,922 ↗ 1,927 Employees	⏸️ No Growth: 0% 10 Employees	Actively Hiring	10	Memphis, Tennessee, United States
97	Ordem dos Farmacêuticos Pharmaceutical	102	Membro do Conselho do Colégio de Especialidade de Farmácia Comunitária, Board Member, College of Specialists in Pharmaceutical Industry, Assistente de comunicação	+76	$500-1,000M		📉 Negative Growth: -0.97% 103 ↘ 102 Employees	⏸️ No Growth: 0% 7 Employees	Not Hiring	0	Lisboa, Portugal
98	Alkem Laboratories Pharmaceutical	5,571	Research Associate, Pharmaceutical, Sales And Marketing Specialist	>100	$500-1,000M	$60M raised Venture Round, 12-08-2015	📉 Negative Growth: -0.54% 5,601 ↘ 5,571 Employees	⏸️ No Growth: 0% 499 Employees	Actively Hiring	18	Mumbai, India
99	MedChemExpress Biotechnology	63	Sales And Marketing Specialist, Regional Sales Manager, Sales Manager	+79	$500-1,000M		📊 Modest Growth: 3.28% 61 ↗ 63 Employees	⏸️ No Growth: 0% 4 Employees	Actively Hiring	7	South Brunswick, New Jersey, United States
100	WuXi AppTec Pharmaceutical	1,936	Research Associate III, Associate Director, Facility Operations, Administrative Assistant to VP	>100	$500-1,000M	$1,500M raised Debt Financing, 03-06-2016	📉 Negative Growth: -1.78% 1,971 ↘ 1,936 Employees	⏸️ No Growth: 0% 83 Employees	Actively Hiring	15	Pudong, China

398

100

Market Expansion

Top Pharmaceutical Companies in Spain

14 October 2025

By Surfe

364

Market Expansion

Top Energy Companies in Germany

14 October 2025

By Surfe

362

Market Expansion

Top Media and Entertainment Companies

03 October 2025

By Surfe

330

100

Market Expansion

Top Financial Services Companies in Germany

14 October 2025

By Surfe

329

100

Intelligent Prospecting, Backed by Signals

What are the key buying criteria for decision-makers in the pharmaceutical industry?

Pharma buys risk reduction first, features second. If a solution cannot pass an audit, it will not pass procurement. Decision-makers look for proof they can defend under scrutiny: documented compliance, audit trails, and data integrity. Think 21 CFR Part 11 and Annex 11 readiness, clear validation documentation, and secure access controls. They also care about time to value. Can this shorten submission timelines, speed a trial start, or reduce deviation rework? Every week saved protects revenue and market share. Security and privacy are nonnegotiable. Expect questions on SOC 2 or ISO 27001, GDPR, HIPAA where applicable, data residency, and vendor incident response. Reliability matters. Downtime during a batch release or safety signal review is a headline risk. One-liner to remember: Compliance is the cover charge, business impact is the headliner.

Beyond that, the buying lens is practical and global. Will it integrate cleanly with what they already use, like ERP, LIMS, safety databases, or CRM, without slowing teams? Can it scale across regions, affiliates, and partners with consistent controls? Procurement will weigh total cost of ownership, not just sticker price. Training, change management, and validation effort are part of the bill. They want a partner, not a ticketing queue. That means proven pharma references, a clear SLA, and support that understands GxP workflows. Vendor stability matters. No one wants to revalidate in 12 months because a startup folded. Sustainability and supply continuity are rising factors, especially for anything touching manufacturing or distribution.

Use these in conversations:
- What audit evidence can we hand your QA on day one?
- How would you measure time saved from trial start to first patient in?
- Which systems must this plug into with zero downtime risk?
- What is your validation and change control plan, and how can we reduce that burden?
- If we had a global rollout tomorrow, what training and localization gaps would worry you most?

Sticky line for your notes: Sell them speed and certainty without adding audit risk.

Which key performance indicators should sales teams focus on when engaging with the pharmaceutical sector?

Pharma buys on proof, risk control, and scale. Speed only counts if it survives compliance. The sellers who win track the friction, not just the forecast. Focus your dashboard on where deals really die: missed buyers, slow reviews, and pilots that never grow. One-liner you can use: If you cannot map compliance, you cannot map revenue.

Start with buyer coverage. Measure buying group coverage ratio by function and seniority. In many pharma deals you need 8 to 12 voices: brand, medical, pharmacovigilance, IT, security, privacy, QA, procurement, and legal. Track meeting to opportunity conversion with a qualified coach inside compliance or medical. Watch stage velocity: days in security assessment, privacy review, MLR review, and procurement. Time to pilot kickoff and time to first value are critical. Define first value clearly, like a validated workflow, an approved data flow, or a live user cohort. Track pilot success rate and pilot to scale conversion within 90 days. Measure security and compliance pass rate at first submission. Monitor RFP or vendor assessment win rate. Once live, watch active user adoption among targeted roles, support SLA adherence during validation, and referenceability rate within 60 to 90 days. For account growth, track multi-brand or cross-function expansion within 6 to 12 months, plus net revenue retention. Tie each KPI to outcomes pharma cares about: faster brand launch execution, fewer rework cycles, cleaner audits, and reduced time to decision.

Conversation starters you can use:
- Which stage stalls most deals for you today: security review, MLR, or procurement?
- How many stakeholders typically sign off, and who gets missed most often?
- What is your pilot to scale conversion rate across vendors in the last 12 months?
- From legal kickoff to PO, what is the average timeline and where are the slips?
- In the first 30 days of a pilot, what evidence convinces compliance and brand to move forward?

Quote to keep handy: Cover the buying group or lose the deal you never knew you had.

What are effective follow-up strategies to improve conversion rates after initial meetings with pharmaceutical industry leaders?

The week after a first meeting decides the quarter. With big pharma, deals rarely die from price. They die from unclear next steps. Win the follow-up by packaging clarity and speed. Within 2 hours, send a crisp recap that a senior leader can forward: problem agreed, business impact, success metric, owners, and the next two dates. Attach a one-page brief or a 90‑second video that their internal champion can reuse with medical, legal, or procurement. Propose a simple mutual action plan aligned to their milestones, like an upcoming submission, a brand planning cycle, or a steering committee. One-liner to keep handy: Make it easy to say yes to the next step, not the whole deal.

Use a tight, multi-channel cadence. Day 0, subject line: Summary, decision path, and draft brief for your team. Day 2, send a small proof of value, like a template, calculator, or a two-slide case from a similar therapy area. Day 5, a LinkedIn note that tags a relevant insight from their earnings call or medical meeting. Day 7, a call with a single choice question. Try lines like, Which of these risks should we tackle first for your team, adoption in the field, privacy review, or evidence for the brand lead. Or, Since you plan to brief leadership by the 15th, here is the two-page sponsor note. Want me to tune the ROI line for procurement. Or, Would a 14‑day pilot with one brand or region help you de-risk the decision.

When silence hits, offer an easy out or a smaller yes. If this slipped behind other priorities, should we pause until post P&T, or keep a 20‑minute working session next week. Multithread with purpose, not spam. Ask your champion, Who else needs to say yes for this to move, brand, IT security, procurement. Then send each persona a tailored asset and a one-sentence ask. For leaders, it is a one-page business case. For security, it is a short checklist. Close every note with a date and a choice. Two slots, two paths. Sell the next 10 yards, not the whole marathon.

How can B2B sales reps tailor their pitches to address the unique pain points of top pharmaceutical companies?

In pharma, the patent clock is the real buyer. The top companies live and die by launch timing, label changes, and payer access. A slow review cycle or a missed signal does not just annoy a brand team. It burns weeks of exclusivity and hands share to a rival. Lead with outcomes they care about: fewer launch delays, fewer compliance risks, faster access wins. One line you can use: they do not buy features, they buy fewer delays.

Frame your pitch around three pressure points. First, MLR speed. Ask, how many review cycles does a typical asset take today, and what would one fewer cycle be worth to your next launch. Offer ways to reduce rework, reuse approved content, and route high risk items earlier. Second, HCP engagement clarity. Ask, where does your field team see the latest approved message and target list, and how fast do payer or field insights get back to marketing. Position faster feedback loops as revenue protection, not tooling. Third, evidence and access storytelling. Ask, how do payer teams see real world results by region or account within a week, not a quarter. Tie it to better formulary wins and fewer do-overs. One-liner: sell fewer review cycles, not more clicks.

If your product touches supply or patient support, stay practical. Stocked vs sold-out is not a logistics story, it is a script-change story for thousands of reps. Ask, can you spot a temperature excursion or a sample gap the same day and trigger the right action without creating audit risk. For patient programs, ask, where are drop-offs highest and who acts on them within 48 hours. Keep the contrast sharp. Smooth launch vs launch firefight. Proactive signal vs late apology. The moral is simple. Speed and certainty compound. Efficiency wins the quarter.

How can understanding the pipeline and R&D focus of pharmaceutical companies enhance sales strategy?

Two thirds of drug launches miss expectations. The teams that read the pipeline early tend to win the calendar. Why? Pipeline mix and R&D bets tell you where budget, leadership attention, and hiring will go next. A company with three Phase 3 oncology assets behaves very differently from one leaning into vaccines or rare disease. Late stage assets trigger launch readiness spend 12 to 18 months before approval. That means money for field expansion, medical affairs tools, payer evidence, patient support, and supply build. Early stage portfolios signal pressure on trial operations, site activation, recruitment, and data workflows. When you can say, based on their filings and trial roster, what is blocking speed to approval or threatening launch revenue, you stop sounding generic. Follow the molecule, find the money. Pipeline intel turns cold outreach into right time conversations.

Turn that insight into timing and talk tracks. Map assets by phase and therapy area from earnings calls, R&D days, 10 K filings, press releases, and ClinicalTrials.gov. Then align your outreach. Oncology heavy and late stage. Lead with KOL mapping, evidence generation, access readiness, and field medical enablement. Vaccine heavy. Lead with demand forecasting, tender strategy, and cold chain coordination. Rare disease. Lead with patient finding, site coverage, and hub services. Use trigger events to land meetings. New Fast Track or Breakthrough designation, a positive pivotal readout, an Advisory Committee date, or a PDUFA clock starts the budget countdown. Ask simple, pointed questions. Which assets are inside 12 months of a decision date. Where are you seeing enrollment friction by site or country. How are you scaling medical and market access for the first 120 days post approval. What will keep your first quarter of launch from sticking. Sell to the calendar, not the org chart.

What techniques can increase engagement and relevance during outreach to executives at major pharmaceutical firms?

A month slip in Phase 3 can erase millions from a launch forecast. That is what your buyer worries about before they open your email. Speak to speed-to-milestone, risk reduction, and patient reach. Use a real trigger so they know you did the work: a ClinicalTrials.gov update, an FDA briefing doc, an earnings call comment on enrollment, a formulary change, a shortage alert, or a patent cliff in the next 12 to 24 months. Then state a clear hypothesis on impact. Example: “Your Q2 call flagged slow site activation in EU5. Teams I work with cut activation by 10 to 15 percent by standardizing start-up packets across CROs. If you pulled first-patient-in forward by 2 weeks, would that keep the readout in fiscal?” Talk milestones, not features. In pharma, relevance is earned with facts that map to label, launch, or lot release.

Keep it short and clinical in tone, but human. Anchor every note to one of four outcomes: accelerate trials, de-risk regulatory, strengthen launch access, or protect supply continuity. Use therapy-area language to show context without jargon. “Atopic dermatitis” beats “dermatology.” Quantify with simple math. “A 5 percent boost to enrollment speed across 40 sites can pull the timeline forward by weeks.” Add peer proof from the same therapeutic area or market size. Offer a safe next step with zero risk to compliance. “Happy to walk your team through a 15-minute playbook on reducing screen failures. No data sharing required.” Close with a sharp question that invites a yes or a no. “Is site start-up or patient recruitment the bigger drag on Q4 milestones?” Two lines that work: “If it does not move a milestone, it is noise.” “Executives buy fewer delays, not more dashboards.”

Conversation starters you can copy:
- I noticed your Phase 2b expanded to 60 sites. Where is the bottleneck today, start-up or screening?
- If we pulled market access pull-through up by 60 days post-approval, how would that change year-one revenue?
- What is the plan to protect supply if demand spikes after guideline updates next quarter?
- Which brand is most at risk from the 2026 patent expiries, and where could field coverage shift protect share?
- Would a 30-minute session with medical affairs and market access to pressure-test the launch sequence be useful?